Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$4 Mln
P/E Ratio
--
P/B Ratio
0.67
Industry P/E
--
Debt to Equity
0.08
ROE
-2.29 %
ROCE
-192.36 %
Div. Yield
0 %
Book Value
6.53
EPS
-10.62
CFO
$-172.31 Mln
EBITDA
$-179.21 Mln
Net Profit
$-186.64 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Nuwellis (NUWE)
| -9.91 | -12.28 | -24.81 | -88.67 | -92.90 | -88.25 | -88.99 |
|
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Nuwellis (NUWE)
| -94.40 | -94.59 | -90.60 | -83.64 | 709.34 | -87.40 | -85.74 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 | -9.70 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 12.93 | 10,562.04 | 12.43 | 12.69 | |
| 72.80 | 10,050.19 | 97.07 | 2.52 | |
| 163.74 | 8,847.72 | -- | -25.23 | |
| 299.78 | 11,550.00 | 278.74 | 3.65 |
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from... fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota. Read more
President, CEO & Director
Mr. Nestor Jaramillo Jr.
President, CEO & Director
Mr. Nestor Jaramillo Jr.
Headquarters
Eden Prairie, MN
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Nuwellis Inc (NUWE) stood at $ 10 Mln as on 31-Dec-24
The share price of Nuwellis Inc (NUWE) is $1.00 (NASDAQ) as of 25-Apr-2025 16:04 EDT. Nuwellis Inc (NUWE) has given a return of -92.9% in the last 3 years.
Nuwellis Inc (NUWE) has a market capitalisation of $ 4 Mln as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Nuwellis Inc (NUWE) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Nuwellis Inc (NUWE) and enter the required number of quantities and click on buy to purchase the shares of Nuwellis Inc (NUWE).
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
The CEO & director of Mr. Nestor Jaramillo Jr.. is Nuwellis Inc (NUWE), and CFO & Sr. VP is Mr. Nestor Jaramillo Jr..
There is no promoter pledging in Nuwellis Inc (NUWE).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,078
|
|
|
1,054
|
|
|
964
|
|
|
853
|
| Nuwellis Inc. (NUWE) | Ratios |
|---|---|
|
Return on equity(%)
|
-218.13
|
|
Operating margin(%)
|
-63.54
|
|
Net Margin(%)
|
-121.56
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Nuwellis Inc (NUWE) was $0 Mln.
$0.07
(
